Tuba Yalçın

12PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Optical technologyPredictive and prognostic markersChiropractic
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 13, 2026
Hydroxytyrosol suppressed the nephrotoxicity of cisplatin while supporting its therapeutic potential in a rat model of hepatocellular carcinoma.

|Mar 29, 2026
Time-dependent integrated tissue and circulating biomarker dynamics of spexin and progranulin in an experimental myocardial infarction model.

Sercan Kaya, Tuba Yalçin

|Mar 19, 2026
Effect of Hydroxytyrosol on OTULIN Levels in Testıcular Tıssue in Experımental Dıabetes Model Induced wıth Streptozotocin.

Tuba Yalçın, Sercan Kaya

|Jul 05, 2025
Linalool May Exert Neuroprotective Effects Against Cadmium-Induced Hippocampal Neurodegeneration by Regulating the 4-HNE/NF-κB Signaling Pathway.

Sercan Kaya, Tuba Yalçın, Devran Ayyıldız

|May 09, 2025
Effect of thymoquinone on hippocampal spexin levels in cisplatin-induced rats.

Tuba Yalçin, Sercan Kaya

|Apr 24, 2024
The Effect of Thymoquinone on the TNF-α/OTULIN/NF-κB Axis Against Cisplatin-İnduced Testicular Tissue Damage.

Tuba Yalçın, Sercan Kaya, Akın Yiğin

Pageof 2

Frequent Collaborators

11 joint publications

Sercan Kaya

4 joint publications

Tuncay Kuloğlu

3 joint publications

Akın Yiğin

2 joint publications

Ahmet Tektemur